151 related articles for article (PubMed ID: 27845418)
1. Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.
Rausalu K; Utt A; Quirin T; Varghese FS; Žusinaite E; Das PK; Ahola T; Merits A
Sci Rep; 2016 Nov; 6():37124. PubMed ID: 27845418
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
3. Mutation of CD2AP and SH3KBP1 Binding Motif in Alphavirus nsP3 Hypervariable Domain Results in Attenuated Virus.
Mutso M; Morro AM; Smedberg C; Kasvandik S; Aquilimeba M; Teppor M; Tarve L; Lulla A; Lulla V; Saul S; Thaa B; McInerney GM; Merits A; Varjak M
Viruses; 2018 Apr; 10(5):. PubMed ID: 29702546
[TBL] [Abstract][Full Text] [Related]
4. Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review.
Wang M; Wang L; Leng P; Guo J; Zhou H
Int J Biol Macromol; 2024 Mar; 262(Pt 2):129949. PubMed ID: 38311132
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.
Merten EM; Sears JD; Leisner TM; Hardy PB; Ghoshal A; Hossain MA; Asressu KH; Brown PJ; Stashko MA; Herring L; Mordant AL; Webb TS; Mills CA; Barker NK; Streblow ZJ; Perveen S; Arrowsmith C; Arnold JJ; Cameron CE; Streblow DN; Moorman NJ; Heise M; Willson TM; Popov K; Pearce KH
bioRxiv; 2024 May; ():. PubMed ID: 38562906
[TBL] [Abstract][Full Text] [Related]
6. Deletion analysis of a defective interfering Semliki Forest virus RNA genome defines a region in the nsP2 sequence that is required for efficient packaging of the genome into virus particles.
White CL; Thomson M; Dimmock NJ
J Virol; 1998 May; 72(5):4320-6. PubMed ID: 9557722
[TBL] [Abstract][Full Text] [Related]
7. Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors.
Kumar P; Kumar D; Giri R
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31443266
[TBL] [Abstract][Full Text] [Related]
8. Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2.
Ware BC; Parks MG; da Silva MOL; Morrison TE
PLoS Pathog; 2024 Mar; 20(3):e1011794. PubMed ID: 38483968
[TBL] [Abstract][Full Text] [Related]
9. Interaction models between peptide substrate and Alphavirus Protease nsP2 of Chikungunya and Mayaro and implications to the mechanism of action.
Lima JCB; Barbosa JARG
J Biomol Struct Dyn; 2023 Dec; 41(20):10851-10858. PubMed ID: 36562200
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus perturbs the Wnt/β-catenin signaling pathway for efficient viral infection.
Chatterjee S; Ghosh S; Datey A; Mahish C; Chattopadhyay S; Chattopadhyay S
J Virol; 2023 Nov; 97(11):e0143023. PubMed ID: 37861335
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Chikungunya virus genome replication by targeting essential RNA structures within the virus genome.
Prosser O; Stonehouse NJ; Tuplin A
Antiviral Res; 2023 Mar; 211():105523. PubMed ID: 36603772
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the genome sequences and replication profiles of chikungunya virus isolates within the East, Central and South African (ECSA) lineage.
Chen KC; Kam YW; Lin RT; Ng MM; Ng LF; Chu JJ
Virol J; 2013 May; 10():169. PubMed ID: 23721429
[TBL] [Abstract][Full Text] [Related]
13. Immunological impact of cytokines on the chikungunya virus pathophysiology: A literature narrative review.
Nunes JAL; Sousa JR; Smith VC; Quaresma JS; Vasconcelos PFDC; Chiang JO
Rev Med Virol; 2023 Jul; 33(4):e2441. PubMed ID: 37021332
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT).
Mishra P; Kumar A; Mamidi P; Kumar S; Basantray I; Saswat T; Das I; Nayak TK; Chattopadhyay S; Subudhi BB; Chattopadhyay S
Sci Rep; 2016 Feb; 6():20122. PubMed ID: 26843462
[TBL] [Abstract][Full Text] [Related]
15. Picornavirus 3C Proteins Intervene in Host Cell Processes through Proteolysis and Interactions with RNA.
Mondal S; Sarvari G; Boehr DD
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140654
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial protein BNIP3 regulates Chikungunya virus replication in the early stages of infection.
Echavarria-Consuegra L; Dinesh Kumar N; van der Laan M; Mauthe M; Van de Pol D; Reggiori F; Smit JM
PLoS Negl Trop Dis; 2023 Nov; 17(11):e0010751. PubMed ID: 38011286
[TBL] [Abstract][Full Text] [Related]
17. The RNA helicase DDX39A binds a conserved structure in chikungunya virus RNA to control infection.
Tapescu I; Taschuk F; Pokharel SM; Zginnyk O; Ferretti M; Bailer PF; Whig K; Madden EA; Heise MT; Schultz DC; Cherry S
Mol Cell; 2023 Nov; 83(22):4174-4189.e7. PubMed ID: 37949067
[TBL] [Abstract][Full Text] [Related]
18. The nsp2 proteins of mouse hepatitis virus and SARS coronavirus are dispensable for viral replication.
Graham RL; Sims AC; Baric RS; Denison MR
Adv Exp Med Biol; 2006; 581():67-72. PubMed ID: 17037506
[TBL] [Abstract][Full Text] [Related]
19. Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of
Ghoshal A; Asressu KH; Hossain MA; Brown PJ; Merten EM; Sears JD; Perveen S; Pearce KH; Popov KI; Moorman NJ; Heise MT; Willson TM
bioRxiv; 2024 Jun; ():. PubMed ID: 38915519
[TBL] [Abstract][Full Text] [Related]
20. Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2.
Ware BC; Parks MG; Morrison TE
bioRxiv; 2023 Nov; ():. PubMed ID: 37961400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
